查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363093

制酸劑市場規模、佔有率和趨勢分析報告：按類型、最終用途、地區、細分趨勢，2023-2030

Antacids Market Size, Share & Trends Analysis Report By Type (Tablet, Liquid), By End-use (Retail Pharmacy, Hospital Pharmacy), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

制酸劑市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球制酸劑市場規模預計將達到87.9億美元，預測期內年複合成長率為3.7%。

偶發胃灼熱的自我治療趨勢是推動市場的主要因素之一。

老年人口的增加預計將對整個制酸劑市場產生積極影響。根據聯合國經濟和社會事務部（DESA）的資料，2017年全球老年人口（60歲以上）約為9.62億。預計這一數字在拉丁美洲成長最快，其中 60 歲及以上人口數量成長了 71%，其次是亞洲（66%）、非洲（64%）、北美（41%）和歐洲（23%）。

經營制酸劑市場的主要企業致力於產品改進以滿足患者需求，例如改變咀嚼片、粉末和果凍等劑型。此外，這些參與者也參與聯盟和收購，以擴大其在市場上的影響力。例如，2017年，輝瑞與Astra Zeneca簽署策略協議，以7.5億印度盧比收購在印度的制酸劑品牌之一Neksium，加強產品系列。

制酸劑很容易在商店購買，為整體市場銷售提供了成長機會。主要參與企業包括GlaxoSmithKline plc、AstraZeneca、Pfizer, Inc.、Sun Pharmaceuticals Industries Ltd.、Dr. Reddy's Laboratories Ltd.、Bayer AG、Takeda Pharmaceutical Company Limited。

制酸劑市場報告亮點

  • 到2022年，錠劑將推動制酸劑市場，因為與其他劑型相比，其功效更高。液體製劑適口性高，受兒童和老年人的喜愛，因此預計會快速成長。
  • 零售藥局因其可近性和可用性而成為領先的配銷通路。由於醫藥 3.0 的普及和消費者意識的提高，線上藥局預計將成為成長最快的領域。
  • 由於GlaxoSmithKline plc、Pfizer Inc.、Abbott等主要參與者的存在，預計亞太地區將成為預測期內成長最快的地區。
  • 由於各種胃腸道疾病的盛行率不斷增加，2022年北美佔據了最大的市場佔有率。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 市場變數、趨勢、範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 普及和成長前景圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 制酸劑市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 市場：類型估計和趨勢分析

  • 制酸劑市場：要點
  • 制酸劑市場：2022年和2030年趨勢和市場佔有率分析
  • 錠劑
  • 液體
  • 其他

第5章 市場：最終用途估計與趨勢分析

  • 制酸劑市場：要點
  • 制酸劑市場：2022年和2030年趨勢和市場佔有率分析
  • 醫院藥房
  • 零售藥房
  • 網路藥房

第6章 市場：區域估計與趨勢分析

  • 區域展望
  • 依地區分類的制酸劑市場：要點
  • 北美洲
    • 2018-2030年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東、非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • GlaxoSmithKline plc.
    • Bayer AG
    • Pfizer, Inc.
    • Boehringer Ingelheim International GmbH
    • Dr. Reddy's Laboratories Ltd.
    • Reckitt Benckiser Group plc.
    • Sanofi
    • Sun Pharmaceuticals Ltd.
    • Takeda Pharmaceutical Company Limited
    • Procter & Gamble
Product Code: GVR-2-68038-693-6

Antacids Market Growth & Trends:

The global antacids market size is expected to reach USD 8.79 billion by 2030, registering a CAGR of 3.7% during the forecast period, according to a new report by Grand View Research, Inc. The trend of self-medication for occasional heartburn is one of the major factors driving the market.

Growing geriatric population is expected to positively impact the overall market for antacid. According to the United Nations Department of Economic And Social Affairs (DESA), the global elderly population (60 years and above), was around 962 million in 2017. This number is expected to grow at the fastest rate in Latin America with 71% increase in population aged 60 and over, followed by Asia with 66%, Africa with 64%, North America with 41%, and Europe with 23%.

Key players operating in antacid market focus on product enhancement to cater to patient requirements, such as changing the dosage form into chewable tablets, powder, and jelly. Also, these players are involved in collaborations and acquisitions to expand their market presence. For instance, in 2017, Pfizer, Inc. entered into a strategic agreement with AstraZeneca to acquire one of the antacid brands, Neksium for a value of INR 75 crores in India to boost its product portfolio.

The easy availability of antacids over-the-counter offer growth opportunities for the sales of overall market. Some of the key players areGlaxoSmithKline plc; AstraZeneca; Pfizer, Inc.; Sun Pharmaceuticals Industries Ltd.; Dr. Reddy's Laboratories Ltd.; Bayer AG; Takeda Pharmaceutical Company Limited.

Antacids Market Report Highlights:

  • In 2022, tablet segment led the antacid market due to high efficacy compared to other dosage forms. Liquid is anticipated to be the fastest growing segment due to its palatable taste and preferred choice for children and elderly population
  • Retail pharmacy led the distribution channel segment due its accessibility and availability. Online pharmacy is anticipated to be the fastest growing segment due to growing adoption of Pharma 3.0 and consumer awareness
  • Asia Pacific is estimated to be the fastest growing region over the forecast period due to presence of key players such as GlaxoSmithKline plc; Pfizer Inc.; and Abbott among others
  • North America held the largest market share in 2022 owing to increasing prevalence of different digestive disorders

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. End-use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Antacids Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Antacids Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Antacids Market: Type Estimates & Trend Analysis

  • 4.1. Antacids Market: Key Takeaways
  • 4.2. Antacids Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Tablet
    • 4.3.1. Tablet market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Liquid
    • 4.4.1. Liquid market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Others
    • 4.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Antacids Market: End-use Estimates & Trend Analysis

  • 5.1. Antacids Market: Key Takeaways
  • 5.2. Antacids Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hospital Pharmacy
    • 5.3.1. Hospital pharmacy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Retail Pharmacy
    • 5.4.1. Retail pharmacy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Online Pharmacy
    • 5.5.1. Online Pharmacy market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Antacids Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Antacids Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. f
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Denmark
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. GlaxoSmithKline plc.
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Bayer AG
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Pfizer, Inc.
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Boehringer Ingelheim International GmbH
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Dr. Reddy's Laboratories Ltd.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Reckitt Benckiser Group plc.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Sanofi
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Sun Pharmaceuticals Ltd.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Takeda Pharmaceutical Company Limited
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Procter & Gamble
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 3 North America antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 4 North America antacids market, by region, 2018 - 2030 (USD Billion)
  • Table 5 U.S. antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 6 U.S. antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 7 Canada antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 8 Canada antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 9 Europe antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 10 Europe antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 11 Europe antacids market, by region, 2018 - 2030 (USD Billion)
  • Table 12 Germany antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 13 Germany antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 14 UK antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 15 UK antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 16 France antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 17 France antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 18 Italy antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 19 Italy antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 20 Spain antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 21 Spain antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 22 Sweden antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 23 Sweden antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 24 Norway antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 25 Norway antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 26 Denmark antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 27 Denmark antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 28 Asia Pacific antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 29 Asia Pacific antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 30 Asia Pacific antacids market, by region, 2018 - 2030 (USD Billion)
  • Table 31 China antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 32 China antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 33 Japan antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 34 Japan antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 35 India antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 36 India antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 37 Australia antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 38 Australia antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 39 Thailand antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 40 Thailand antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 41 South Korea antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 42 South Korea antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 43 Latin America antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 44 Latin America antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 45 Latin America antacids market, by region, 2018 - 2030 (USD Billion)
  • Table 46 Brazil antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 47 Brazil antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 48 Mexico antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 49 Mexico antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 50 Mexico antacids market, by application, 2018 - 2030 (USD Billion)
  • Table 51 Argentina antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 52 Argentina antacids market, by application, 2018 - 2030 (USD Billion)
  • Table 53 Middle East and Africa antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 54 Middle East and Africa antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 55 Middle East and Africa antacids market, by region, 2018 - 2030 (USD Billion)
  • Table 56 South Africa antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 57 South Africa antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 58 Saudi Arabia antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 59 Saudi Arabia antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 60 Saudi Arabia antacids market, by application, 2018 - 2030 (USD Billion)
  • Table 61 UAE antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 62 UAE antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 63 Kuwait antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 64 Kuwait antacids market, by end-use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approach
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Antacids: Market outlook
  • Fig. 9 Antacids: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Antacids market driver impact
  • Fig. 15 Antacids market restraint impact
  • Fig. 16 Antacids market strategic initiatives analysis
  • Fig. 17 Antacids market: Type movement analysis
  • Fig. 18 Antacids market: Type outlook and key takeaways
  • Fig. 19 Tablet market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Liquid market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Antacids market: End-use class movement analysis
  • Fig. 23 Antacids market: End-use outlook and key takeaways
  • Fig. 24 Hospital pharmacy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Retail pharmacy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Online pharmacy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Global antacids market: Regional movement analysis
  • Fig. 29 Global antacids market: Regional outlook and key takeaways
  • Fig. 30 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Europe. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)